Mobile Menu

Genomics week in brief: Week ending 21st August

Check out the latest research and news from across the genomics space in this week’s Genomics Week in Brief.

Top stories from the past week

  • Researchers have developed a new system, called SEND, that can deliver molecular medicines to cells. (Segel et al, 2021)
  • A study of East Africans has illuminated new genetic factors underlying human faces. (Liu et al, 2021)
  • New findings have revealed that the Npas4 gene may be a master timekeeper for the brain’s circadian clock. (Xu et al, 2021)
  • According to a new study, a child’s educational success depends on the genes that they have not inherited from their parents. (Wang et al, 2021)
  • Investigators who previously developed a process to convert skin cells into immature muscle cells have now reported the molecular changes that this process trigger. These insights could help treat muscle-related diseases. (Yagi et al, 2021)
  • A team of researchers has developed a new CRISPR-based technology, called MIC-Drop, that could help speed up the identification of genes involved in health and disease. (Parvez et al, 2021)
  • A new study has found that rare, single-nucleotide variants in the MX1 gene increase human susceptibility to zoonotic H7N9 avian influenza infection. (Chen et al, 2021)
  • Researchers have discovered a master regulatory gene (FOSL1) for the mesenchymal subtype of glioblastoma, which is considered to be the brain cancer with the poorest prognosis. (Marques et al, 2021)
  • Scientists have found a novel mechanism for a circRNA, called circURI1, in inhibiting gastric cancer metastasis. (Wang et al, 2021)

In other news

  • Moderna are set to start Phase I human trials of its experimental mRNA HIV vaccine. (Parkins, 2021)
  • Pluto Biosciences has launched from Harvard’s Wyss Institute with the aim of commercialising a cloud-based life sciences data management platform to speed up scientific discovery. (Wyss Institute, 2021)
  • A multi-disciplinary group has been awarded a $26.5-million grant from the National Institutes of Health (NIH) to try a completely new strategy for curing HIV. (Weill Cornell Medicine, 2021)

Image credit: canva


More on these topics

CRISPR / Genomic Medicine / Genomics / Week in brief

Share this article